Rafeh Naqash, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center, shared a post on X:
“Next Sunday June 1 ASCO, don’t forget to mark your calendars and join Jennifer Carlisle, Melissa L. Johnson, Melinda Hsu and myself to discuss about T-cell engagers Amivantamab and more! I will be talking about Bispecific T cell engagers, current and future!”
Rafeh Naqash shared his post, adding:
“Now online ASCO EduBook article led by Jennifer Carlisle and others from our upcoming Education session June 2. We discuss novel Bispecifics Abs in NSCLC and Tox management approaches. Have a read!”
More posts featuring ASCO.
